Methylprednisolone Terminated Phase 3 Trials for Prostate Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00003682Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer